Raul L. Marquez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 25, 2025
Porta hepatis disease. A challenge in ovarian cancer surgery.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 04, 2025
Clinical outcomes and subsequent therapy in patients with platinum-sensitive recurrent ovarian cancer deriving long-term benefit from maintenance niraparib: a subgroup analysis of the GEICO-88R study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 11, 2025
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 27, 2023
Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.
Journal: Gynecologic oncology reports
Published: April 16, 2023
MgO-mediated activation of active carbon as an affordable strategy to "in situ" degradation of lindane in contaminated soils.
Journal: Journal of environmental management
Published: March 29, 2023
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.
Journal: Journal of personalized medicine
Published: September 26, 2022
Breast metastases from a serous ovarian carcinoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 01, 2022
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial.
Journal: Molecular oncology
Published: May 31, 2014
Last Updated: 09/26/2026